[
  {
    "ts": "2025-09-15T13:01:00+00:00",
    "headline": "AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta",
    "summary": "This listing is a new step towards more equitable access to mental illness medication in Canada.  As up to 90% of Canadians with serious mental illness are unemployed3, public plan coverage is critical for people to access the medications they need to manage their symptoms.  VRAYLAR® is already listed in all provinces and by federal programs including Non-Insured Health Benefits (NIHB), Correctional Service Canada (CSC) and Veterans Affairs Canada (VAC) for the treatment of schizophrenia.",
    "url": "https://finance.yahoo.com/news/abbvies-vraylar-cariprazine-now-publicly-130100698.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "3b7b3024-1845-32e1-8656-bc9bc241bdb9",
      "content": {
        "id": "3b7b3024-1845-32e1-8656-bc9bc241bdb9",
        "contentType": "STORY",
        "title": "AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta",
        "description": "",
        "summary": "This listing is a new step towards more equitable access to mental illness medication in Canada.  As up to 90% of Canadians with serious mental illness are unemployed3, public plan coverage is critical for people to access the medications they need to manage their symptoms.  VRAYLAR® is already listed in all provinces and by federal programs including Non-Insured Health Benefits (NIHB), Correctional Service Canada (CSC) and Veterans Affairs Canada (VAC) for the treatment of schizophrenia.",
        "pubDate": "2025-09-15T13:01:00Z",
        "displayTime": "2025-09-15T13:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/7c4915b53aa85aa7764c79bb9311730f",
          "originalWidth": 400,
          "originalHeight": 218,
          "caption": "VRAYLAR® (CNW Group/AbbVie Canada)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2PaO7238P2e_dBGJwq.o.w--~B/aD0yMTg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7c4915b53aa85aa7764c79bb9311730f.cf.webp",
              "width": 400,
              "height": 218,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OE8sEzI.ydcP29S.Ht5DEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7c4915b53aa85aa7764c79bb9311730f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvies-vraylar-cariprazine-now-publicly-130100698.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvies-vraylar-cariprazine-now-publicly-130100698.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-15T13:00:00+00:00",
    "headline": "Saisei Ventures Appoints James Feliciano as Venture Partner",
    "summary": "CAMBRIDGE, Mass., September 15, 2025--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr. James Feliciano has been appointed venture partner.",
    "url": "https://finance.yahoo.com/news/saisei-ventures-appoints-james-feliciano-130000485.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0b7c5ff2-c4f3-3563-84da-57f87764adcd",
      "content": {
        "id": "0b7c5ff2-c4f3-3563-84da-57f87764adcd",
        "contentType": "STORY",
        "title": "Saisei Ventures Appoints James Feliciano as Venture Partner",
        "description": "",
        "summary": "CAMBRIDGE, Mass., September 15, 2025--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr. James Feliciano has been appointed venture partner.",
        "pubDate": "2025-09-15T13:00:00Z",
        "displayTime": "2025-09-15T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a4b2daa9c6ccc7ca0756b4c915a7e367",
          "originalWidth": 395,
          "originalHeight": 480,
          "caption": "James Feliciano, Venture Partner",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/psm9JmQVqCIxiUaHA5peDQ--~B/aD00ODA7dz0zOTU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a4b2daa9c6ccc7ca0756b4c915a7e367.cf.webp",
              "width": 395,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BM9L_OxwK8220EAFTbGhiQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a4b2daa9c6ccc7ca0756b4c915a7e367.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/saisei-ventures-appoints-james-feliciano-130000485.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/saisei-ventures-appoints-james-feliciano-130000485.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "MRK.DE"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]